O'Shaughnessy, J A <br/><br/>
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Oct 1994 
 - 709-16 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/oxfordjournals.annonc.a058975  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Dyspnea--etiology<br/>Escherichia coli<br/>Fluorouracil--administration & dosage<br/>Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Hypotension--etiology<br/>Leucovorin--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Neutropenia--chemically induced<br/>Recombinant Proteins--adverse effects<br/>Regression Analysis<br/>Remission Induction<br/>Survival Rate